Ph2 Open-label study of ZL-1310 in subjects with Neuroendocrine Carcinoma
Phase II Clinical Trial
ZL-1310-002: A Phase 1b/2 Open-label Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors
Participating Locations
ZL-1310-002: A Phase 1b/2 Open-label Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors